Cutis. 2004 Jul;74(1 Suppl):10-5.

Onychomycosis: review of recurrence rates, poor prognostic factors, and strategies to prevent disease recurrence.

Source

Division of Dermatology, Department of Medicine, Sunnybrook and Women's College Health Sciences Center (Sunnybrook site), the University of Toronto, Canada.

Abstract

Treatment of onychomycosis is associated with substantial disease reappearance rates. Identification of factors associated with therapeutic failure may help develop strategies to prevent recurrence of onychomycosis. Aspects of a patient's health and lifestyle, local factors involving the nail, therapeutic options, and environmental conditions are associated with poor therapeutic response. Strategies to reduce recurrence of disease involve the reduction of both relapse (delayed failure) and reinfection. The topical antifungal agent ciclopirox nail lacquer, may be a consideration for prophylaxis of this chronic disease.

PMID:: 15287395; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

Antifungal Agents

LinkOut - more resources

Medical

Skin Infections - MedlinePlus Health Information

Supplemental Content

Related citations

Review Ciclopirox nail lacquer solution 8% in the 21st century. [J Am Acad Dermatol. 2000]
Review Ciclopirox nail lacquer solution 8% in the 21st century.
Gupta AK, Baran R. J Am Acad Dermatol. 2000 Oct; 43(4 Suppl):S96-102.
Review Ciclopirox nail lacquer: a brush with onychomycosis. [Cutis. 2001]
Review Ciclopirox nail lacquer: a brush with onychomycosis.
Gupta AK. Cutis. 2001 Aug; 68(2 Suppl):13-6.
Review Onychomycosis in clinical practice: factors contributing to recurrence. [Br J Dermatol. 2003]
Review Onychomycosis in clinical practice: factors contributing to recurrence.
Scher RK, Baran R. Br J Dermatol. 2003 Sep; 149 Suppl 65:5-9.
Successful treatment of onychomycosis with ciclopirox nail lacquer: a case report. [Cutis. 2001]
Successful treatment of onychomycosis with ciclopirox nail lacquer: a case report.
Galitz J. Cutis. 2001 Aug; 68(2 Suppl):23-4.
Review Topical antifungal drugs for the treatment of onychomycosis: an overview of current strategies for monotherapy and combination therapy. [J Eur Acad Dermatol Venereol. 2005]
Review Topical antifungal drugs for the treatment of onychomycosis: an overview of current strategies for monotherapy and combination therapy.
Baran R, Kaoukhov A. J Eur Acad Dermatol Venereol. 2005 Jan; 19(1):21-9.

See reviews... See all...

Recent activity

Clear Turn Off Turn On

Onychomycosis: review of recurrence rates, poor prognostic factors, and strategi...
Onychomycosis: review of recurrence rates, poor prognostic factors, and strategies to prevent disease recurrence.
Cutis. 2004 Jul ;74(1 Suppl):10-5.

PubMed
Minocycline for acne vulgaris: efficacy and safety.
Minocycline for acne vulgaris: efficacy and safety.
Cochrane Database Syst Rev. 2000 ;(2):CD002086.

PubMed
Randomized clinical trials of weight loss maintenance: a review.
Randomized clinical trials of weight loss maintenance: a review.
J Cardiovasc Nurs. 2009 Jan-Feb ;24(1):58-80.

PubMed
Interventional treatment of the carcinoid syndrome.
Interventional treatment of the carcinoid syndrome.
Neuroendocrinology. 2004 ;80 Suppl 1:67-73.

PubMed
ARACHNE: a whole-genome shotgun assembler.
ARACHNE: a whole-genome shotgun assembler.
Genome Res. 2002 Jan ;12(1):177-89.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

Onychomycosis: review of recurrence rates, poor prognostic factors, and strategies to prevent disease recurrence.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Medical

Supplemental Content

Related citations

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information